Follow
Payal Jain
Payal Jain
Senior Translational Scientist, Servier Pharmaceuticals
Verified email at servier.com
Title
Cited by
Cited by
Year
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism
P Bandopadhayay, LA Ramkissoon, P Jain, G Bergthold, J Wala, R Zeid, ...
Nature genetics 48 (3), 273-282, 2016
2772016
A pilot precision medicine trial for children with diffuse intrinsic pontine glioma—PNOC003: A report from the Pacific Pediatric Neuro‐Oncology Consortium
S Mueller, P Jain, WS Liang, L Kilburn, C Kline, N Gupta, E Panditharatna, ...
International journal of cancer 145 (7), 1889-1901, 2019
1102019
Purification of mRNA encoding chimeric antigen receptor is critical for generation of a robust T-cell response
JB Foster, N Choudhari, J Perazzelli, J Storm, TJ Hofmann, P Jain, ...
Human gene therapy 30 (2), 168-178, 2019
992019
CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles
ACRAJW P Jain, T M Fierst, H J Han, T E Smith, A Vakil, P J Storm
Oncogene, 2017
722017
Genomic Analysis of Dysembryoplastic Neuroepithelial Tumor Spectrum Reveals a Diversity of Molecular Alterations Dysregulating the MAPK and PI3K/mTOR Pathways
LF Surrey, P Jain, B Zhang, J Straka, X Zhao, BN Harding, AC Resnick, ...
Journal of Neuropathology & Experimental Neurology 78 (12), 1100-1111, 2019
502019
Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways
P Jain, A Silva, HJ Han, SS Lang, Y Zhu, K Boucher, TE Smith, A Vakil, ...
Oncotarget 8 (49), 84697, 2017
462017
Upfront biology-guided therapy in diffuse intrinsic pontine glioma: therapeutic, molecular, and biomarker outcomes from PNOC003
C Kline, P Jain, L Kilburn, ER Bonner, N Gupta, JR Crawford, A Banerjee, ...
Clinical Cancer Research 28 (18), 3965-3978, 2022
352022
Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases
ACR Harry J Han, Payal Jain
Bone, 2017
34*2017
Novel FGFR2-INA fusion identified in two low-grade mixed neuronal-glial tumors drives oncogenesis via MAPK and PI3K/mTOR pathway activation
P Jain, LF Surrey, J Straka, M Luo, F Lin, B Harding, AC Resnick, ...
Acta Neuropathologica 136, 167-169, 2018
242018
Sclerosing Epithelioid Fibrosarcoma of the Bone With Rare EWSR1-CREB3L3 Translocation Driving Upregulation of the PI3K/mTOR Signaling Pathway
A Shenoy, L Surrey, P Jain, J Foster, J Straka, A Resnick, A Waanders, ...
Pediatric and Developmental Pathology 22 (6), 594-598, 2019
142019
BRAF fusions in pediatric histiocytic neoplasms define distinct therapeutic responsiveness to RAF paradox breakers
P Jain, LF Surrey, J Straka, P Russo, R Womer, MM Li, PB Storm, ...
Pediatric Blood & Cancer 68 (6), e28933, 2021
102021
OpenPBTA: The Open Pediatric Brain Tumor Atlas
JA Shapiro, KS Gaonkar, SJ Spielman, CL Savonen, CJ Bethell, R Jin, ...
Cell Genomics, 2023
92023
annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions
KS Gaonkar, F Marini, KS Rathi, P Jain, Y Zhu, NA Chimicles, MA Brown, ...
BMC bioinformatics 21, 1-21, 2020
82020
MYB-QKI drives childhood brain tumors via tripartite mechanism
P Jain, AC Resnick
Cell Cycle 16 (5), 390-391, 2017
62017
An open pediatric brain tumor atlas
JA Shapiro, CL Savonen, CJ Bethell, KS Gaonkar, Y Zhu, MA Brown, ...
Manubot, 2022
52022
Discovery and functional characterization of the oncogenicity and targetability of a novel NOTCH1–ROS1 gene fusion in pediatric angiosarcoma
P Jain, S Iyer, J Straka, LF Surrey, J Pogoriler, H Han, T Smith, C Busch, ...
Molecular Case Studies 8 (6), a006222, 2022
42022
OMIC-14. OPENPBTA: AN OPEN PEDIATRIC BRAIN TUMOR ATLAS
J Shapiro, C Savonen, C Bethell, K Gaonkar, Y Zhu, M Brown, N Duong, ...
Neuro-Oncology 23 (Supplement_1), i40-i40, 2021
12021
LG-25PEDIATRIC LOW-GRADE GLIOMAS WITH CRAF GENE FUSIONS RESPOND DIFFERENTIALLY TO TARGETED THERAPEUTICS BASED ON DIMERIZATION PROFILES
P Jain, T Fierst, A Silva, A Vakil, H Han, PJ Storm, AJ Waanders, ...
Neuro-Oncology 18 (Suppl 3), iii84, 2016
12016
LG-02 MYB-QKI REARRANGEMENTS IN ANGIOCENTRIC GLIOMA DRIVE TUMORIGENICITY THROUGH A TRIPARTITE MECHANISM
G Bergthold, P Bandopadhayay, L Ramkissoon, P Jain, J Wala, ...
Neuro-Oncology 18 (suppl_3), iii78-iii78, 2016
12016
LGG-04. CLINICALLY RELEVANT MODELING OF FUSION-DRIVEN PEDIATRIC LOW GRADE GLIOMAS USING DROSOPHILA MELANOGASTER
G Jung, P Jain, Z Liang, F Li, K Rathi, X Chen, J Straka, M Koptyra, ...
Neuro-Oncology 25 (Suppl 1), i55, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20